Gracell Biotech of Suzhou Completes $85 Million Series B for Immune Cell Gene Therapies Feb 25, 2019 Life Science
PharmaEssentia and AOP Orphan Receive EU Approval of Besremi™ (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU Feb 22, 2019 Life Science
Medic Vision’s iQMR™ System to Allow 40% MRI Scan-Time Reduction in More Than 350 Medical Centers in China, Under a Multi-Million Dollar Agreement Feb 15, 2019 Life Science
